טוען...
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes
Autoimmune diabetes mellitus is a rare but significant side effect of treatment with immune checkpoint inhibitors. Immune checkpoint inhibitor‐induced diabetes mellitus (CPI‐DM) is characterized by acute onset of dramatic hyperglycemia with severe insulin deficiency and occurrence following exposure...
שמור ב:
| הוצא לאור ב: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160652/ https://ncbi.nlm.nih.gov/pubmed/32027018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13424 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|